BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19854254)

  • 1. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.
    Nanjwade BK; Singh J; Parikh KA; Manvi FV
    Int J Pharm; 2010 Jan; 385(1-2):176-80. PubMed ID: 19854254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended release of high pI proteins from alginate microspheres via a novel encapsulation technique.
    Wells LA; Sheardown H
    Eur J Pharm Biopharm; 2007 Mar; 65(3):329-35. PubMed ID: 17156984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entrapment of andrographolide in cross-linked alginate pellets: II. Physicochemical characterization to study the pelletization of andrographolide.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):9-15. PubMed ID: 17337421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
    Rawat M; Singh D; Saraf S; Saraf S
    Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic evaluation of alginate nanoparticle-encapsulated azole antifungal and antitubercular drugs against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Nanomedicine; 2007 Sep; 3(3):239-43. PubMed ID: 17652032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
    Ahmad Z; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
    Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
    Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
    Pandey R; Ahmad Z; Sharma S; Khuller GK
    Int J Pharm; 2005 Sep; 301(1-2):268-76. PubMed ID: 16023808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
    Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
    Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
    Wang S; Jiang T; Ma M; Hu Y; Zhang J
    Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
    Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
    Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.